Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05929807
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-16
First Post:
2023-06-06
Brief Title:
A Clinical Trial to Investigate Long-term Safety Tolerability and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
Sponsor:
Ascendis Pharma Growth Disorders AS
Organization:
Ascendis Pharma AS
Organization Data
Organization:
Ascendis Pharma AS
Class:
INDUSTRY
Study ID:
ASND0039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascendis Pharma Growth Disorders AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None